MAPT and Alzheimer disease: Notably, after the application of exogenous recombinant Pin1 to AD brain sections, it has been observed that recombinant Pin1 was bound to the phosphorylated Thr231 residue of tau and it was sequestered within tangles, thereby reducing the amount of soluble Pin1 protein [13].